Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents.
about
Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based TherapyEngineering mesenchymal stem cells for regenerative medicine and drug deliveryEffect of methotrexate on bone and wound healing.Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest.Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors.Assessment of whole spine vertebral bone marrow fat using chemical shift-encoding based water-fat MRI.Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation.Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapyCharacterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.Bone marrow osteoblast damage by chemotherapeutic agents.Adipose-derived stem cells retain their regenerative potential after methotrexate treatment.Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients.Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells.Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study.Extracellular Protease Inhibition Alters the Phenotype of Chondrogenically Differentiating Human Mesenchymal Stem Cells (MSCs) in 3D Collagen MicrospheresMesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin.Factors affecting mesenchymal stromal cells yield from bone marrow aspiration.Mesenchymal stem cells are sensitive to bleomycin treatment.Disparate Response to Methotrexate in Stem Versus Non-Stem CellsMethotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents.Drug-induced amino acid deprivation as strategy for cancer therapy.Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro.Epac Activation Regulates Human Mesenchymal Stem Cells Migration and Adhesion.Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.Cytosine arabinoside reduces the numbers of granulocyte macrophage colony forming cells (GM-CFC) and high proliferative potential colony forming cells (HPP-CFC) in vivo in mice.Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells.Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment.Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.RE: stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.Protease inhibitors enhance extracellular collagen fibril deposition in human mesenchymal stem cells.Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.Bidirectional and mutually beneficial interactions between human mesenchymal stem cells and osteoarthritic chondrocytes in micromass co-cultures.Functional intrinsic and extrinsic apoptotic pathways in human fetal mesenchymal stem cells.Marrow adipose tissue imaging in humans.Human mesenchymal stem cells lose their functional properties after paclitaxel treatment.
P2860
Q26742060-6859C3FB-9DE7-4F2E-8346-B79CE9BCB7D1Q27026414-C7ECF154-897B-4494-987D-C881CD89DEE1Q30235141-04257D2E-DCED-4B59-8B02-CEEAAA0B327DQ30313560-04D1BD88-8242-406F-BA36-AAD0A9574280Q30847857-63033930-0EDF-4383-B3FF-DA3E2E8948EFQ30886918-AFABBE08-B1FA-4EDE-829C-66F96B1CCCF0Q33494191-D5BA25DD-1CFB-4DAF-B41E-917716D8036EQ33903974-A256A62B-4086-45A9-B8BE-5F9113F44DDDQ34038564-575843C8-2634-4F6A-95F0-A450B15FC0DBQ34113542-786DC1FA-B8F4-49B7-A7EB-CD8398C62C0EQ34120467-090B0C8F-8B62-4FBA-A6FD-D0C8C401A2BAQ34170223-3E7CEB97-FA35-4057-B793-7E5107166861Q34183849-BC7604E7-5CE9-4F43-B244-DEF7A6B8C6E4Q34602114-64B6FCCE-BD35-464C-9855-15CD5729CB63Q35390924-39CC8EF7-9E1A-44AB-8AC1-E183B522EA08Q35677647-E9B9FDA5-8C95-4E71-96B3-750822DE51BEQ35866337-8ACAD241-56C7-4BAF-8125-402CD5BCF672Q35892672-B5CD92DB-7498-4204-BAA6-ADD8132BBE8AQ36500869-E78F54A0-8DE4-41A9-94FA-26295973C331Q36654578-08DBAED8-8040-4667-A195-B58A845AC3ABQ36928779-39001445-0CBC-4443-8EBF-954239B21D49Q36936301-993139A6-FED7-4874-BA5B-FCFE69C520EBQ37871863-DCE6808F-C585-4E1B-818E-C9D257580BF3Q38531783-554B08FC-B6DE-4827-BCAD-96932BC35B5BQ38657061-A6BFD75B-C151-4DE6-8021-E919C798B943Q38783878-B26E131C-D374-4420-BA2E-6F355BB04700Q38925089-A422E1D3-3107-4F7C-A7CB-3789F64D0511Q38972307-7A0EA5EA-360B-4A19-AA73-956988AB3899Q39435891-57A6CE3E-D2A1-49C8-B315-0175AED7180AQ39793760-AD40E747-2BE4-4EFA-A6F4-A138F1BB95A0Q40739842-0C42BEAC-F4EA-4512-B425-82059E9B2238Q40902576-010BEF33-C41A-4EA7-A9B0-4F7427B1F61AQ42553878-00B8AF03-5193-430B-BABF-6FD5752620B3Q42592707-941ED030-ECFA-4332-8DA6-E13BA1F50D57Q43238735-08A43414-A355-40E2-BE03-391CDFD67D6CQ44498168-84615557-DC23-476D-9A72-D12419BB09CAQ45790070-02E2D954-0CF6-4E5D-ABC0-2A3A814B9DD4Q46551931-54AB0D72-32E8-43AC-889F-A994BA3F2359Q47718042-56C21287-ADB4-4436-A47E-BCA8E0B46707Q49166619-BA04C90C-5C82-41FF-BFB7-F57A8ACF74B2
P2860
Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Differential damage and recove ...... re to chemotherapeutic agents.
@en
type
label
Differential damage and recove ...... re to chemotherapeutic agents.
@en
prefLabel
Differential damage and recove ...... re to chemotherapeutic agents.
@en
P2093
P1476
Differential damage and recove ...... ure to chemotherapeutic agents
@en
P2093
Godfrey Chi Fung Chan
Yu Lung Lau
P304
P356
10.1111/J.1365-2141.2004.05200.X
P407
P577
2004-11-01T00:00:00Z